Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.
about
Hyperhemolytic Syndrome Complicating a Delayed Hemolytic Transfusion Reaction due to anti-P1 Alloimmunization, in a Pregnant Woman with HbO-Arab/β-Thalassemia.Peptide inhibitor of complement C1 modulates acute intravascular hemolysis of mismatched red blood cells in rats.Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activation.Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab.Etiopathological mechanisms and clinical characteristics of hyperhemolysis syndrome in Spanish patients with thalassemia.Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease
P2860
Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Hyperhemolysis syndrome in a p ...... to treatment with eculizumab.
@en
type
label
Hyperhemolysis syndrome in a p ...... to treatment with eculizumab.
@en
prefLabel
Hyperhemolysis syndrome in a p ...... to treatment with eculizumab.
@en
P2093
P2860
P356
P1433
P1476
Hyperhemolysis syndrome in a p ...... to treatment with eculizumab.
@en
P2093
Andrew Fenves
David B Sykes
Sandra Taddie Nance
Shruti Gupta
Walter Sunny Dzik
P2860
P304
P356
10.1111/TRF.12876
P577
2014-09-26T00:00:00Z